SCHEMBL29431626

SCHEMBL29431626

c1cnc2[nH]cnc2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10759 1.00
Hydrochloric Acid SCHEMBL29424070 0.98 MAPK1 (0.46)
Ammonia Solution, Strong SCHEMBL8971987 0.98 MAPK1 (0.46)
SCHEMBL2446692 0.98 MAPK1 (0.46)
Formic Acid SCHEMBL29774382 0.88 KMT2A (0.42)
SCHEMBL28135793 0.84 QPCT (0.49)
SCHEMBL8653543 0.82 TLR8 (0.35)
Trifluoroacetic Acid SCHEMBL29858985 0.82 L3MBTL1 (0.40)
SCHEMBL1809684 0.80 KDM4E (0.33)
SCHEMBL28135193 0.80 DAO (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP claimed
CN-119661811-A Latent accelerator based on anhydride-tertiary amine dynamic ion pair, preparation method and application thereof 江南大学 2025-03-21 CN claimed
CN-119654326-A Novel heterocyclic compounds 豪夫迈·罗氏有限公司 2025-03-18 CN claimed
CN-114174294-B Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2024-10-25 CN claimed
CN-118786130-A Substituted imidazopyridinyl compounds useful as TLR9 inhibitors 百时美施贵宝公司 2024-10-15 CN claimed
WO-2024097172-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2024-05-10 WO claimed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 CN claimed
CN-113679717-B Methods for inhibiting fascin 康奈尔大学 2026-05-22 CN disclosed
CN-122011353-A Imidazopyridine catalyst for liquid crystal polyarylester synthesis and application thereof 浙江海利得科技有限公司 2026-05-12 CN disclosed
EP-4735420-A1 ARYL INDOL-3-YL KETONE AND ARYL INDAZOL-3-YL KETONE INHIBITORS OF KIF18A Volastra Therapeutics, Inc. (US) 2026-05-06 EP disclosed
CN-121986101-A 3H-imidazo [4,5-b ] pyridine compounds as non-covalent modifiers of AKT1 and uses thereof 特瑞莫托生物科学股份有限公司 2026-05-05 CN disclosed
EP-4683909-A2 ATM KINASE INHIBITORS Eberhard Karls Universität Tübingen (DE) 2026-01-28 EP disclosed
WO-2025236100-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2025-11-20 WO disclosed
CN-110062761-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-05-13 CN disclosed
WO-2022099011-A1 BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF CYTOKINETICS, INC. (US) 2022-05-12 WO disclosed
EP-3990442-A1 RHO KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation, Inc. (US) 2022-05-04 EP disclosed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN disclosed
CN-112021322-B Compositions and methods for controlling pests 住友化学株式会社 2022-04-01 CN disclosed
CN-114269383-A Metalloenzyme inhibitor compounds 菲斯生物制药公司 2022-04-01 CN disclosed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 CN disclosed